Accuray Incorporated · NASDAQ:ARAY
Accuray — Q2 FY2026 Earnings Presentation
16 slides from Accuray's earnings presentation, Feb 17, 2026
Slide 1: Q2'FY26 Earnings Call Supplemental Presentation
Q2'FY26 Earnings Call BceuRey Supplemental Presentation February 17, 2026 aaa
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Safe Harbor Statement Statements in this presontction (cluding the oral commentary that accompanies it) that ore not statements of historical fact are fomarctlooking
Slide 3: Vision and Mission
ACCURAY Vision and Mission To expand the curative power of radiation therapy to improve as many lives as possible. To think, act, and execute beyond expectations every day to deliver better, safer radiation therapy solutions and help patients get back to living their lives, faster.
Slide 4: Q2 FY26 and 1H FY26 Financials
Q2’°FY26 and 1H’FY26 Financials Strong financial performance KEY FINANCIAL METRICS SD GD ED GDED Revenues $1022M 12% $196.2M 10% $450M -26% $822M -25% SOI2M 4% SIMAOM 8% Gross Margin $24IM -43% $51IM -33% Op. Expenses $356M -4% $740M Flat ‘Adj. EBITDA! — ($L9M) 120% ($6.0M) 147% 2 Q2 FY'26 Highlight
Slide 5: China Deferred Margin Impact
China Deferred Margin Impact Total Deferral impact, sk Not China Margin impact (eter!) / Reease Totel Gross Margin % Reported Gross Margin % (Excl China Margin impact) ' Adjusted EBITDA (Reported) Adjusted EB11DA % ‘Adjusted EBIIDA (Exc! China Margin impact) ? Adjusted EBITDA (Excl China Margin impa
Slide 6: RPO Disclosure Change
RPO Disclosure Change As provided in our Form 10-K/A and the 10-Q/A filed on February 17, 2026, we revised prior disclosure for remaining performance obligations ("RPO") included in Note 2, Revenue. Below is a short summary of such RPO related disclosures. ‘Only the Company's RPO financial disclosur
Slide 7: FY26 Guidance
FY26 Guidance* ACCURAY Revised Guidance Range Revenue 2% to-4% [revised as of 2/4/26] [revised as of 2/4/26] Adjusted EBITDA’ {fascugonce selective os aignay communtctedonFabraay 4.208, "Ajusedtine anon upmost. ane abe SiS sauna ot Adkste TDA otha meat tect carpareie GMP maoaita oe ee
Slide 8: Thank you
ACCURAY Thank you opictryardConienialopenyeticcuray 8
Slide 9: GAAP to Adjusted EBITDA Q2 FY26 and Q2 FY25
GAAP to Adjusted EBITDA Q2 FY’26 and Q2 FY’25 Reconciliation of Net income (toss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization ACCURAY and Stock-Based Compensation (Adjusted EBITDA) Three Months Ended December 31 $k 2025 2024 GAAP net loss 7 | s 207 | Depreciation and amor
Slide 10: GAAP to Adjusted EBITDA 1H FY26 and 1H FY25
GAAP to Adjusted EBITDA 1H FY’26 and 1H FY’25 Reconciliation of Net income (toss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization ACCURAY and Stock-Based Compensation (Adjusted EBITDA) () coneists a depreciation on property and equipment andamortzoton of anges (©) Consists of
Slide 11: GAAP to Adjusted EBITDA Q1 FY26 and Q1 FY25
GAAP to Adjusted EBITDA Q1 FY’26 and QI FY’25 Reconciliation of Net income (Loss) to Adjusted Earnings Before Interest, Taxes, Depreciation, Amortization ‘and Stock-Based Compensation (adjusted EBITDA) ACCURAY Three Months Ended September 30, ‘x 2025 72028 GAAP net oss ls (as) |] s (954) T Depreciat
Slide 12: GAAP to Adjusted EBITDA FY2025
GAAP to Adjusted EBITDA FY2025 Reconciliation of Net Income (Loss) to Adjusted Earnings Before interest, Taxes, Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA) ‘Twelve Months Ended “June 20, ‘x 2025 GAAP net loss $ (1991) Depreciation and amortization 180 stock- based compe
Slide 13: GAAP to Adjusted EBITDA FY26 — Forward Looking Guidance
GAAP to Adjusted EBITDA FY’26 — Forward Looking Guidance Reconciliation of Net Income (Loss) to Adjusted Earnings Before Interest, Taxes, ACCURAY Depreciation, Amortization and Stock-Based Compensation (Adjusted EBITDA) ‘Twelve Months Ended, June 30, 2026 ‘x From to aap netioss s (9000) || s (26000)
Slide 14: Gross Margin to Gross Margin Excluding China Margin Impact Q2 FY26
Gross Margin to Gross Margin Excluding China Margin Impact Q2 FY’26 ACCURAY Reconciliation of Gross margin to Gross margin excluding China Margin Impact Three Months Ended December 3, 8K 2025 Total Net Revenue s 102,241 Total Cost of Revenue (78,169) Gross Profit, 24072 China Margin Release 1220 ‘Gr
Slide 15: Gross Margin to Gross Margin Excluding China Margin Impact Q1 FY26
Gross Margin to Gross Margin Excluding China Margin Impact Q1 FY’26 ACCURAY Reconciliation of Gross margin to Gross margin excluding China Margin Impact Three Months Ended September 20, $k 2028 Total Net Revenue $ 93.942 Total Cost of Revenue (68931) Gross Profit 27,00 Chine Margin Deferral (108i) ‘
Slide 16: Gross Margin to Gross Margin Excluding China Margin Impact FY25
Gross Margin to Gross Margin Excluding China Margin Impact FY25 Reconciliation of Gross margin to Gross margin excluding China Margin Impact ACCURAY Twelve Months Ended une 20, $k 2028 Total Net Revenue $ 498505 Total Cost of Revenue (ens) Gross Profit 146967 Chine Margin Deferral (7886) ‘Gross Prof